Ordinary Index Rebalancing in the Solactive Transatlantic Healthcare Equity Index | October 2020

In the ordinary rebalance the following composition will be implemented effective open 08.10.2020:

ABBOTT LABORATORIES
ABBVIE INC
AGILENT TECHNOLOGIES INC
AMGEN INC
BAXTER INTL.
BECTON DICKINSON AND CO
BIO-RAD LABORATORIES INC
BRISTOL-MYERS SQUIBB CO
CHINA BIOLOGIC PRODUCTS HOLD
CHR HANSEN HOLDING AS
COLOPLAST AS CLASS B
COOPER COMPANIES INC
DANAHER CORP
ELI LILLY & CO
ESSILORLUXOTTICA
FRESENIUS MEDICAL CARE AG & CO KGAA
FRESENIUS SE & CO KGAA
GENMAB A/S
GILEAD SCIENCES INC
GRIFOLS SA CLASS A
HUMANA INC
ICU MEDICAL INC
IDEXX LABORATORIES INC
IONIS PHARMACEUTICALS INC
JOHNSON & JOHNSON
KONINKLIJKE PHILIPS NV
LONZA GROUP AG
MASIMO CORPORATION
MEDTRONIC PLC
MERCK & CO. INC.
MERCK KGAA
NOVARTIS AG
NOVO NORDISK A/S
NOVOZYMES AS CLASS B
PERKINELMER INC
PFIZER INC
QIAGEN NV
RECORDATI SPA
ROCHE HOLDING AG
SANOFI SA
SIEMENS HEALTHINEERS AG
STERIS PLC
SWEDISH ORPHAN BIOVITRUM AB
TECAN GROUP AG-REG
TELEFLEX INC
THERMO FISHER SCIENTIFIC INC
UNITEDHEALTH GROUP INC
VIFOR PHARMA AG
WRIGHT MEDICAL GROUP NV
ZOETIS INC